News for uniQure N.V. (0EE0.L)

~ Announced alignment with the U.S. Food and Drug Administration (FDA) on key elements of the Accelerated Approval pathway for AMT-130 in Huntington's disease;

**media[552098]**

uniQure's stock rises on Huntington's therapy progress and strong gene therapy pipeline. Learn about QURE stock's cost-cutting measures and analyst support.

**media[528038]**

One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.

We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold in 2025. In this article, we are going to take a look at where uniQure N.V.

uniQure N.V. (QURE), Wednesday announced the pricing of underwritten public offering of around 4.4 million shares at $17 per share, raising a total of nearly $75 million.

**media[508723]**

LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced

uniQure CFO Christian Klemt sells $13,559 in stock

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling by around 0.1% on Tuesday. The Dow traded down 0.02% to 44,393.25 while the NASDAQ...

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded up 0.02% to 44,412.05 wh...

U.S. stocks were mixed, with the Nasdaq Composite gaining around 100 points on Tuesday. Shares of United Natural Foods, Inc. UNFI rose sharply during Tuesday's...

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down...

Westford, USA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Gene Therapy Market will reach a value of USD 38.34 Billion by 2031,...

Loading... Loading... Shares of Conagra Brands, Inc. CAG fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales res...

Loading... Loading... Shares of SeaStar Medical Holding Corporation ICU fell sharply during Wednesday's session after the company entered into a $10 million re...

Loading... Loading... Shares of Helen of Troy Limited HELE fell sharply during Tuesday's session after the company reported soft first-quarter earnings and low...

Voyager Therapeutics investors need to be patient as the biotech targets hard to treat Alzheimer's and Parkinson's. Read why the best days are ahead for VYGR stock.